Results 171 to 180 of about 13,693 (208)

Development of a multi-epitope vaccine from outer membrane proteins and identification of novel drug targets against <i>Francisella tularensis</i>: an <i>In Silico</i> approach. [PDF]

Front Immunol
Moradkasani S, Esmaeili S, Asadi Karam MR, Mostafavi E, Shahbazi B, Salek Farrokhi A, Chiani M, Badmasti F.   +7 more
europepmc   +1 more source

Wild lagomorphs as potential sources of <i>Francisella tularensis</i> in an urban zoo: a case study. [PDF]

J Vet Diagn Invest
Maddock KJ, Rickey CV, Pecoraro HL.
europepmc   +1 more source

Investigation of Francisella tularensis Seroprevalence and Determination of Risk Factors for Tularemia among Hunters in Northern Cyprus. [PDF]

J Arthropod Borne Dis
Güler E, Güvenir M, Korbay B, Kiraz A, Süer K.   +4 more
europepmc   +1 more source

Confirmed Case of Longstanding Respiratory Francisella tularensis holarctica Infection: Nebraska, 2022. [PDF]

Clin Infect Dis
Birn R, Hamik J, Dayne L, Frederick J, Bartling A, Iwen PC, Wells A, Donahue M.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Francisella tularensis aortitis

Infection, 2015
Francisella tularensis, the agent of tularemia, is a Gram-negative coccobacillus primarily pathogen for animals and occasionally for humans. The clinical manifestations of tularemia include pneumonia, ulceroglandular, oropharyngeal, or typhoidal disease. Rare manifestations are also described, but to our knowledge, we describe here the first case of F.
Briére, M., Kaladji, A., Douane, F., Breux, J. P., Touroult-Jupin, P., Boisset, S., Edouard, S., Biron, C., Boutoille, D.   +8 more
openaire   +4 more sources

Francisella tularensis vaccines

Vaccine, 2009
Francisella tularensis has attracted attention historically as a biological weapon, due to its high infectivity in aerosols, and the severity of disease in humans. There is no licensed vaccine currently available, although an attenuated live vaccine strain (LVS) was identified in the middle of the last century and has been successfully used to protect ...
openaire   +2 more sources

Vaccination strategies for Francisella tularensis

Advanced Drug Delivery Reviews, 2005
Francisella tularensis is the etiologic agent of tularemia, a severe debilitating disease of humans and animals. The low infectious dose of F. tularensis in humans and the relative ease of culture are probably the properties which originally attracted interest in this bacterium as a bioweapon. Even today, F. tularensis is ranked as one of the pathogens
Karen E, Isherwood, Richard W, Titball, D Huw, Davies, Phillip L, Felgner, W John W, Morrow   +4 more
openaire   +2 more sources

Field Detection of Francisella tularensis

Scandinavian Journal of Infectious Diseases, 2000
A field investigation was undertaken following an outbreak of water-borne tularemia in Northern Norway. Francisella tularensis bacterial cellular components were analysed by rapid immunochromatography (RI)-testing, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).
B P, Berdal, R, Mehl, H, Haaheim, M, Løksa, R, Grunow, J, Burans, C, Morgan, H, Meyer   +7 more
openaire   +2 more sources

Vaccines Against Francisella Tularensis

Annals of the New York Academy of Sciences, 2007
Abstract:  Francisella tularensis is one of the most pathogenic pathogens known, especially when disseminated as a small particle aerosol. Because of this, it was developed into a biological warfare agent by several states during the 20th century.
Conlan, J. Wayne, Oyston, Petra C.F.
openaire   +3 more sources

Francisella tularensis meningitis

Médecine et Maladies Infectieuses, 2011
L, Contentin, J, Soret, O, Zamfir, O, Gontier, T, Lherm, M, Hamrouni, A, Ouchenir, G, Monchamps, P, Kalfon   +8 more
openaire   +2 more sources